Wan-Ping Hsieh

Statistics

Publications

Citations

H-Index

Active since

2008

Affiliations

National Health Research Institutes(Current)

Wan-Ping Hsieh is an author at National Health Research Institutes specializing in cannabinoid pharmacology, cannabinoid receptor pharmacology, and cannabinoid structure-activity relationships.

Publications per year

2008–2016

Publications

Discovery of 2-[5-(4-Chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-ethyl-1H-pyrazol-3-yl]-1,5,5-trimethyl-1,5-dihydro-imidazol-4-thione (BPR-890) via an Active Metabolite. A Novel, Potent and Selective Cannabinoid-1 Receptor Inverse Agonist with High Antiobesity Efficacy in DIO Mice

Chien-Huang Wu, Ming‐Shiu Hung, Jen‐Shin Song et al. · Journal of Medicinal Chemistry · 2009 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Bioisosteric Replacement of the Pyrazole 5-Aryl Moiety ofN-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A). A Novel Series of Alkynylthiophenes as Potent and Selective Cannabinoid-1 Receptor Antagonists

Shi-Liang Tseng, Ming‐Shiu Hung, Chun‐Ping Chang et al. · Journal of Medicinal Chemistry · 2008 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

The effects of mass rapid transit station on the house prices in Taipei: the hierarchical linear model of individual growth

Fen‐May Liou, Shih-Yu Yang, Borliang Chen et al. · Pacific Rim Property Research Journal · 2016 · 13 citations

Social Sciences, Economics, Real Estate +17

Biphasic suppression of appetite by cannabinoid CB1 receptor antagonists with distinct functional activities

Yinchiu Lin, Kak‐Shan Shia, Wen‐Chi Hsiao et al. · Pharmacological Research · 2010 · 11 citations

Medicine, Neuroscience, Pharmacology +12

1–4 of 4